Biomerica, Inc. (BMRA) Financials
BMRA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Aug. 31, 2026 | 8.1 million | 4.4 million |
| May 31, 2026 | 6.8 million | 4.1 million |
| Feb. 28, 2026 | 4.9 million | 1.6 million |
| Nov. 30, 2025 | 6.0 million | 1.6 million |
BMRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Aug. 31, 2026 | -802000 | 134000 |
| May 31, 2026 | -949000 | 418000 |
| Feb. 28, 2026 | -1.3 million | 135000 |
| Nov. 30, 2025 | -954000 | -210000 |
BMRA Net Income
No data available :(
BMRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Aug. 31, 2026 | 2.7 million | - | 1.8 million |
| May 31, 2026 | 1.3 million | 1.6 million | 1.9 million |
| Feb. 28, 2026 | 1.3 million | - | 193000 |
| Nov. 30, 2025 | 2.5 million | - | 284000 |
BMRA Shares Outstanding
BMRA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Aug. 31, 2026 | - | 206000 | 1.1 million | - |
| May 31, 2026 | 37000 | 205000 | 1.3 million | - |
| Feb. 28, 2026 | 37000 | 178000 | 1.1 million | - |
| Nov. 30, 2025 | 37000 | 193000 | 1.2 million | - |
BMRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Aug. 31, 2026 | 1.3 million | 1.2 million |
| May 31, 2026 | 875000 | 946000 |
| Feb. 28, 2026 | 987000 | 1.0 million |
| Nov. 30, 2025 | 1.2 million | 1.2 million |
BMRA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BMRA
Price: $1.72
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 8300
Ebitda: -223324Market Capitalization: 7.9 million